Bezuclastinib

CAS No. 1616385-51-3

Bezuclastinib( —— )

Catalog No. M35498 CAS No. 1616385-51-3

Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 432 In Stock
10MG 692 In Stock
25MG 1378 In Stock
50MG 2158 In Stock
100MG 3432 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bezuclastinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.
  • Description
    Bezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Kit
  • Recptor
    c-Kit
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1616385-51-3
  • Formula Weight
    331.37
  • Molecular Formula
    C19H17N5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1[nH]nc(C(=O)Nc2cnc3[nH]c(cc3c2)-c2ccccc2)c1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cistanoside A

    Cistanoside A possesses protective activities on CCl4 induced hepatotoxicity in mice, which is involved with increasing free radicals clearing activities.

  • KBP-7018

    A novel potent, multikinase inhibitor with IC50 of 10, 7.6 and 25 nM for c-Kit, RET and PDGFRβ, respectively.

  • CS-2660

    CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.